<Record>
<Term>Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Recombinant Viral Vaccine</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Vaccine/Recombinant Viral Vaccine/Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine</BroaderTerm>
<BroaderTerm>Recombinant Viral Vaccine</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Vaccine</BroaderTerm>
<Synonym>AVX701</Synonym>
<Synonym>CEA(6D) VRP</Synonym>
<Synonym>Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine</Synonym>
<Source>NCI Thesaurus</Source>
</Record>
